mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000

View company profile
Please contact the Account Manager for opportunities with this organisation

Boehringer Ingelheim to collaborate with Priaxon

Posted on 19/01/2010 in Pharmaceutical Company Product News

Boehringer Ingelheim revealed this week that it plans to collaborate with Priaxon for the development of mdm2/p53 inhibitors - which have the potential to treat various types of tumour.

Priaxon will bring its proprietary small molecule drug discovery expertise to the partnership, which is well-suited to investigate inhibition of protein-protein interactions.

Boehringer Ingelheim will lead development and commercialisation of the mdm2/p53 inhibitor products and will make upfront payments to Priaxon for research and discovery projects.

The compound constituting the main focus of the collaboration - p53 - is a human tumour suppressor protein and may hold tumour-suppressing qualities.

Dr Wolfgang Rettig, corporate senior vice-president of research at Boehringer Ingelheim, commented: "The discovery of p53 and its protein-protein interactions in a broad range of human cancers has been a milestone in cancer biology, yet finding potent inhibitors of these interactions has been challenging."

Last month, Boehringer Ingelheim announced that it had instigated a clinical study into one of its ovarian cancer therapies - the compound BIBF 1120.

Other news stories from 19/01/2010

Read more in the Zenopa News Archive

How this news is generated

Becky
Account Manager
for this opportunity

01494 818 026
(Mon to Fri 0830 to 1800 hours)
becky@zenopa.com

Latest News

Boehringer Ingelheim granted priority review for atrial fibrillation drug

Boehringer Ingelheim marks 125th anniversary

Boehringer Ingelheim pays milestone sum to research partner Evotec

Boehringer Ingelheim meets expectations in Q2 2010

Boehringer Ingelheim Vetmedica wins EU approval for FLEXcombo

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use